IIT: Ph2 Home Care Study Autologous Hematopoietic Stem Cell Transplantation

Purpose of this Study

We are doing this study to compare the outcomes of people who get their after-transplant care in the hospital versus in their home. This study is important to learn if getting after-transplant care in a patient's home can lead to better outcomes.

Who Can Participate?

Eligibility

Adults ages18-80 who:
  • Are scheduled to get an autologous stem cell transplant for any type of illness
  • Are able to read and write in English
  • Have a home that is close to Duke, or are staying in approved temporary lodging (e.g., hotel) that is close to Duke
The caregivers of people receiving these transplants can also participate. For more information about who can join this study, please contact the study team at andrea.pires@duke.edu or 919-668-4978.

Age Range

18-80

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you choose to join the study, you will:
  • Be randomly assigned (like a coin flip) to either get your after-transplant care in the hospital or in your home/temporary lodging
  • Fill out questionnaires
  • Collect home surface samples
  • Give stool samples
  • Have your skin swabbed
  • Have blood draws
  • Do hand grip tests and 6-minute walk tests
  • Complete cognitive function tests
  • Use an Apple Watch and iPhone to track your activity and complete daily entries in an app
If your caregiver chooses to join the study, they will:
  • Fill out questionnaires
  • Collect home surface samples
  • Give stool samples
  • Have their skin swabbed

    • Locations

    Duke University Hospital
    Other

    Visit Timing

    Weekdays

    Compensation

    Yes

    Spanish Materials Available

    No

    Study Details

    Full Title

    A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

    Principal Investigator

    Nelson
    Chao

    Protocol Number

    PRO00089697

    NCT ID

    NCT03667599

    Phase

    II

    Enrollment Status

    Open to Enrollment
    ClinicalTrials.gov